Publikationsliste von Prof. Dr. Susanne Alban

09.01.2017

I. Originalarbeiten:

Schoenfeld AK, Lahrsen E, Alban S
Regulation of Complement and Contact System Activation via C1 Inhibitor Potentiation and Factor XIIa Activity Modulation by Sulfated Glycans - Structure-Activity Relationships
PLoS One (2016) 11(10): e0165493. PubMed
 

Schneider T, Ehrig K, Liewert I, Alban S
Interference with the CXCL12/CXCR4 axis as potential antitumor strategy: superiority of a sulfated galactofucan from the brown alga Saccharina latissima and Fucoidan over heparins
Glycobiology (2015) 25(8): 812-824. PubMed

Ehrig K, Alban S
Sulfated Galactofucan from the Brown Alga Saccharina latissima-Variability of Yield, Structural Composition and Bioactivity
Mar Drugs (2014) 13(1): 76-101. PubMed

Schoenfeld A-K, Vierfuss S, Luehn S, Alban S
Testing of potential glycan-based heparanase inhibitors in a fluorescence activity assay using either bacterial heparinase II or human heparanase
J Pharm Biomed Anal (2014)95: 130-138. PubMed

Eller T, Busse J, Dittrich M, Flieder T, Alban S, Knabbe C, Birschmann I
Dabigatran, rivaroxaban, apixaban, argatroban and fondaparinux and their effects on coagulation POC and platelet function tests
Clin Chem Lab Med (2014) 52(6): 835-44. PubMed

Luehn S, Grimm JC, Alban S
Simple and rapid quality control of sulfated glycans by a fluorescence sensor assay--exemplarily developed for the sulfated polysaccharides from red algae Delesseria sanguinea
Mar Drugs (2014)12(4): 2205-27. PubMed

Schiemann S, Luehn S, Alban S
Development of both colorimetric and fluorescence heparinase activity assays using fondaparinux as substrate
Anal Biochem (2012) 427(1): 82-90. PubMed

Alban S, Luehn S, Schiemann S, Beyer T, Norwig J, Schilling C, Raedler O, Wolf B, Matz M, Baumann K, Holzgrabe U
Comparison of established and novel purity tests for the quality control of heparin by means of a set of 177 heparin samples
Anal Bioanal Chem (2011) 399(2): 605-620. PPubMed

Luehn S, Schiemann S, Alban S
Simple fluorescence assay for quantification of OSCS in heparin
Anal Bioanal Chem (2011) 399(2): 673-80. PubMed

Alban S, Luehn S, Schiemann S
Combination of a two-step fluorescence assay and a two-step anti-Factor Xa assay for detection of heparin falsifications and protein in heparins
Anal Bioanal Chem (2011) 399(2): 681-690. PPubMed

Beyer T, Matz M, Brinz D, Raedler O, Wolf B, Norwig J, Baumann K, Alban S, Holzgrabe U
Composition of OSCS-contaminated heparin occurring in 2008 in batches on the German market
Eur J Pharm Sci (2010) 40(4):297-304. PubMed

Lühn S, Schrader T, Sun W, Alban S
Development and evaluation of a fluorescence microplate assay for quantification of heparins and other sulfated carbohydrates.
J Pharm Biomed Anal (2010) 52(1):1-8. PubMed

Grünewald N, Alban S
Optimized and Standardized Isolation and Structural Characterization of Anti-inflammatory Sulfated Polysaccharides from the Red Alga Delesseria sanguinea ( Hudson ) Lamouroux (Ceramiales, Delesseriaceae)
Biomacromolecules (2009) 10(11):2998-3008 PubMed

Grünewald N, Groth I, Alban S
Evaluation of seasonal variations of the structure and anti-inflammatory activity of sulfated polysaccharides extracted from the red alga Delesseria sanguinea (Hudson) Lamouroux (Ceramiales, Delesseriaceae)
Biomacromolecules (2009) 10(5):1155-1162. PubMed

Groth I, Grünewald N, Alban S
Pharmacological profiles of animal- and non-animal-derived sulfated polysaccharides – comparison of unfractionated heparin, the semisynthetic glucan sulfate PS3, and the sulfated polysaccharide fraction isolated from Delesseria sanguinea
Glycobiology (2009) 19: 408-417; Epub (2008) Dec 23 PubMed

Alban S, Ludwig R, Bendas G, Schön MP, Oostingh G, Radeke HH, Fritzsche J, Pfeilschifter J, Kaufmann R, Boehncke W-H
PS3, a novel semisynthetic β-1,3-glucan-sulfate, diminishes contact hypersensitivity responses through inhibition of L- and P-selectin functions
J Invest Dermatol (2009) 129: 1192-1202; Epub (2008) Dec 4 PubMed

Alban S, Lühn S
Prothrombin Time for Detection of Contaminated Heparins
New Engl J Med (2008) 359: 2732-2734. Epub 2008 Dec. 3, selected for “online first” PubMed

Groth I, Alban S
Elastase inhibition assay with peptide substrates – an example for the limited comparability of in vitro results
Planta Medica (2008) 74: 852-858. PubMed

Greinacher A, Alban S, Omer-Adam MA, Weitschies W, Warkentin TE
Heparin-induced thrombocytopenia: A stoichiometry-based model to explain the different immunogenicities of unfractionated heparin, low-molecular-weight heparin, and fondaparinux
Thromb Res (2008) 122: 211-220. PubMed

Simonis D, Christ K, Alban S, Bendas G
Affinity and kinetics of different heparins binding to P- and L-selectin.
S
emin Thromb Hemost (2007) 33: 534-539 PubMed

Simonis D, Fritzsche J, Alban S, Bendas G
Kinetic analysis of heparin and glucan sulfates binding to P-selectin and its impact on the general understanding of selectin inhibition.
Biochemistry (2007) 46: 6156-6164 PubMed

Bauersachs R, Alban S
Perioperative bridging with fondaparinux in a woman with antithrombin deficiency.
Thromb Haemost (2007) 97: 498-499 PubMed

Volk RB, Venzke K, Blaschek W, Alban S
Complem ent modulating and anticoagulant effects of a sulfated exo polysaccharide released by the cyanobacterium Synechocystis aquatilis.
Planta Med (2006) 72: 1424-1427 PubMed

Gauczynski S, El-Gogo S, Papy-Garcia D, Alban S, Barritault D, Lasmézas CI, Weiss S
Interference of pentosan polysulfate and heparan sulfate mimetics with the 37 kDa/67 kDa LRP/LR dependent binding of the mouse scrapie prion protein
J Infect Dis (2006) 194: 702-709

Fritzsche J, Alban S, Ludwig RJ, Rubant S, Boehncke WH, Schumacher G, Bendas G
The influence of various structural parameters of semisynthetic sulfated polysaccharides on the P-selectin inhibitory capacity.
Biochem Pharmacol (2006) 72: 474-485 PubMed

Ludwig RJ, Alban S, Bistrian R, Boehncke WH, Kaufmann R, Henschler R, Gille J
The ability of different forms of heparins to suppress P-selectin function in vitro correlates to their inhibitory capacity on blood-borne metastasis in vivo.
Thromb Haemost (2006) 95: 535-540 PubMed

Al Dieri R, Alban S, Beguin S, Hemker HC
Fixed dosage of low-molecular-weight heparins causes large individual variation in coagulability, only partly correlated to body weight.
J Thromb Haemost (2006) 4: 83-88. PubMed

Ludwig RJ, Schindewolf M, Alban S, Kaufmann R, Lindhoff-Last E, Boehncke WH
Molecular weight determines the frequency of delayed type hypersensitivity reactions to heparin and synthetic oligosaccharides.
Thromb Haemost (2005) 94:1265-1269 PubMed

Fritzsche J, Hünerbein I, Schumacher G, Alban S, Ludwig R, Gille J, Bendas G
In vitro investigation on the selectin binding mechanisms in tumor cell metastasis and their inhibition by heparin.
Int J Clin Pharmacol Ther (2005) 43: 570-572 PubMed

Alban S
Chromogenic assay for functional determination of TFPI
Hämostaseol (2005) 25: 286 – 292 PubMed

Ménard R, Alban S, de Ruffray P, Jamois F, Franz G, Fritig B, Yvin J-C, Kauffmann S
ß-1,3 Glucan sulfate, but not ß-1,3 glucan, induces the salicylic acid signaling pathway in tobacco and Arabidopsis
The Plant Cell (2004) 16: 3020-3032 PubMed

Al Dieri R, Alban S, Béguin S, Hemker HC
Thrombin generation for the control of heparin treatment, comparison to the activated partial thromboplastin time.
J Thromb Haemost (2004) 2: 1395-1401 PubMed

Türk H, Haag R, Alban S
Dendritic polyglycerol sulfates as heparin analogues and potent inhibitors of the complement system
Bioconjugate Chem (2004) 15:162-167 PubMed

Höpfner M, Alban S, Schumacher G, Rothe U, Bendas G
Selectin-blocking semisynthetic sulfated polysaccharides as promising antiinflammatory agents
J Pharm Pharmacol (2003) 55: 697-706 PubMed

Becker M, Franz G, Alban S
Inhibition of PMN-elastase activity by semisynthetic glucan sulfates
Thromb Haemost (2003) 89: 915-925 PubMed

Alban S, Classen B, Blaschek W
Differentiation between the complement modulating effects of an arabinogalactan-protein from Echinacea purpurea and of heparin
Planta Med (2002) 68: 1118-1124 PubMed

Alban S, Welzel D, Hemker HC
Pharmacokinetic characterization of a new medium molecular weight heparin in comparison with an UFH and a LMWH
Semin Thromb Hemost (2002) 28: 369-377 PubMed

Alban S, Gastpar R
Development of SPC-ELISA, a new assay principle for the study of sulfated polysaccharide-protein interactions
J Biomol Screen (2001) 6: 393-400 PubMed

Alban S
MW-Dependent influence of heparin on the form of TFPI circulating in plasma
Semin Thromb Hemost (2001) 27: 503-512 PubMed

Alban S, Schauerte A, Franz G
Anticoagulant sulfated polysaccharides: I. Synthesis and structure-activity relationships of new pullulan sulfates
Carbohydr Polym (2001) 47: 267-276 PubMed

Alban S, Franz G
Partial synthetic glucan sulfates as potential new antithrombotics
Biomacromolecules (2001) 2: 354-361

Alban S, Gastpar R
Plasma levels of total and free tissue factor pathway inhibitor (TFPI) as individual pharmacological parameters of various heparins
Thromb Haemost (2001) 85: 824-829 (selected as “Journal Club Highlights” in Clin Lab (2001) 47: 426) PubMed

Füller E, Sosa S, Tubaro A, Alban S, Franz G, Della Loggia R
Anti-inflammatory activity of Chamomile polysaccharides
Pharm Pharmacol Lett (2000) 10: 86-87 link

Alban S, Gastpar R
In vitro influence of heparin on plasma total and free tissue factor pathway inhibitor (TFPI) as measured by ELISA
Pharm Pharmacol Lett (2000) 10: 51-54

Alban S, Franz G
Characterization of the anticoagulant actions of a semisynthetic curdlan sulfate
Thromb Res (2000) 99: 377-388 PubMed

Bergé J-P, Bourgougnon N, Alban S, Pojer F, Billaudel S, Chermann J-C, Robert JM, Franz G
Antiviral and anticoagulant activities of a water soluble fraction of the marine diatom Haslea ostrearia
Planta Med (1999) 65: 604-609 PubMed

Alban S, Franz ME, Franz G
Influence of the therapeutically used enzymes bromelain, papain and trypsin on the blood coagulation in vitro
Pharm Pharmacol Lett (1997) 7: 59 -62

Kiefl B, Alban S, Franz G
Storage stability of herbal drugs containing essential oils / Storage stability and related aspects of Juniperus communis L.
Proceedings of the 27 th International Symposium of Essential Oils (1997) Allured Publishing Corp., 312-314

Franz G, Alban S
Structure-activity relationship of antithrombotic polysaccharide derivatives
Int J Biol Macromol (1995) 17/6: 311-314

Franz G, Alban S, Kraus J
Novel pharmaceutical applications of polysaccharides
Macromol Symp (1995) 99: 187-200 PubMed

Hoffman R, Paper DH, Donaldson J, Alban S, Franz G
Characterisation of a laminarin sulphate which inhibits basic fibroblast growth factor binding and endothelial cell proliferation
J Cell Sci (1995) 108: 3591-3598 PubMed

Greinacher A, Alban S, Dummel V, Franz G,. Mueller-Eckhardt C
Characterization of the structural requirements for a carbohydrate based anticoagulant with reduced risk of inducing the immunological type of heparin-associated thrombocytopenia
Thromb Haemost (1995) 74(3): 886-892 PubMed

Alban S, Jeske W, Hoppensteadt D, Fareed J, Franz G
Synthesis and testing of a defined curdlan sulfate with anticoagulant, antiaggregation and anti-thrombotic activity
Pharm Pharmacol Lett (1995) 5(2):70-73

Alban S, Jeske W, Welzel D, Franz G, Fareed J
Anticoagulant and antithrombotic actions of a semisynthetic β-1,3-glucan-sulfate
Thromb Res (1995) 78: 201-210 PubMed

Alban S, Franz G
Anticoagulant activity of β-1,3-glucan sulfates in dependence on their molecular weight
Pure Appl Chem (1994) 66, 10/11: 2403-2406

Alban S, Franz G
Gas-liquid chromatography-mass spectrometry analysis of anticoagulant active curdlan sulfates
Semin Thromb Hemost (1994) 20, 2: 152-158 PubMed

Alban S, Kraus J, Franz G
Synthesis of laminarin sulfates with anticoagulant activity
Arzneim-Forsch / Drug Res (1992) 42 (II), 8: 1005-1008 PubMed

Alban S, Harenberg J
Neutralization of heparins and heparin-related-oligosaccharides by protamine and polybrene
Pharm Pharmacol Lett (1991) 1, 1: 37 -40

 

II. Übersichtsartikel:

Alban S, Dingermann T, Griese N, Kämmerer W, Schubert-Zsilavecz M, Schulz M, Trenk D, Zagermann-Muncke P.
Klinisch relevante Interaktion zwischen Clopidogrel und Protonenpumpeninhibitoren
Pharm Unserer Zeit (2009) 38(4): 370-371

Alban S
Prasugrel - ein neuer ADP-Rezeptor-Antagonist. Prodrug-Aktivierung als entscheidender Unterschied
Pharm Unserer Zeit (2009) 38(4): 320-328

Alban S, Dingermann T
Thrombozytenaggregationshemmer. Editorial
Pharm Unserer Zeit (2009) 38(4): 295.

Alban S
Zertifizierte Fortbildung: Das Antikoagulans Dabigatranetexilat
u.a. erschienen in: apotheke + marketing (2009) 18(03): 42-50
Zertifizierte Fortbildung Pharmazie, Rubrik „Neue Arzneistoffe“ des Springer-CME-Fortbildungsportal (www.cme.springer.de)
http://www.springer-gup.de/media/pdf/fuer_alle_lesbar/AuM/ausgabe_03_09/03_09_aum_42_48.pdf

Alban S
Paradigmenwechsel in der Antikoagulation?
Vascular Care (2009) 19: 4-5

Alban S
Die gegenwärtigen Regularien für pflanzliche Produkte sind insuffizient
NaturaMed Forschung und Praxis (2009) 24: 14-15

Knöss W, Alban S
Pflanzliche Arzneimittel für Kinder. Fencheltee und Co.
Pharm Unserer Zeit (2009) 38(1): 50-53

Alban S
Pharmakologie der Heparine und direkten Antikoagulanzien
Hämostaeologie (2008) 28: 400-420

Alban S, Dingermann T, Blume H, Schubert-Zsilavecz M.
Stellungnahme der DPhG zur geplanten Health-Claims-Verordnung.
Pharm Unserer Zeit (2008) 37: 424-425

Alban S
Niedermolekulare Heparine wirklich alle gleich?
Vascular Care (2008) 15(2): 8-23

Alban S
Pharmacological strategies for inhibition of thrombin activity
Curr Pharm Design (2008) 14: 11 52-1175

Alban S.
Natural and synthetic glycosaminoglycans: Molecular characteristics as the basis of distinct drug profiles.
Hämostaseologie (2008) 28: 51–61

Koscielny J, Alban S
Perioperatives Management von patienten unter ASS-/Clopidogrel-Medikation
Vascular Care (2008) 14: 28 -43

Alban S
Molekulare Charakteristika als Grundlage unterschiedlicher Arzneistoffprofile
MedReport (2008) 32: 2-3

Alban S
Antikoagulanzien: Der steinige Weg zu Innovationen
Pharm Ztg (2007) 152(23): 14-23

Alban S
Thrombozytenaggregationshemmer und Antikoagulantien
Pharm Ztg (2007) 152 (PZ-Sonderheft Meran): 26-30

Ludwig RJ, Alban S, Boehncke WH
Structural requirements of heparin and related molecules to exert a multitude of anti-inflammatory activities.
Mini Rev Med Chem (2006) 6: 1009-1023

Alban S, Schröder S, Wätzig H
Pflanzliche Arzneimittel: Hohe Qualität sicherstellen.
Pharm Ztg (2006) 151(46): 86-89.

Alban S
Spezielle Pharmakologie Niedermolekularer Heparine
MedReport (2006) 30: 8

Alban S
Niedermolekulare Heparine – Individuelle Arzneimittel oder Analogpräparate?
Ärztliches Journal Orthopädie (2006) 7(3): 34-37

Alban S
Transparenz bei Ginkgo-Präparaten
Dtsch Apo Ztg (2006) 146(11): 80

Alban S, Schygula Ch
Delesseria sanguinea (Lamouroux) – eine viel versprechende Alge aus der Ostsee mit wirtschaftlichem Potential?
Fischerei und Fischmarkt in M-V (2006) 6(1): 25-28

Alban S
Phytopharmaka für verschiedene Lebensalter
Pharm Ztg (2006) 151 (PZ-Sonderheft Davos): 43-46

Alban S
Venöse Thromboembolie - Medikamentöse Behandlungsoptionen
Ringvorlesung.de (2005) (http://www.eumecom.de/rv_index.php)

Alban S
The ‘precautionary principle’ as a guide for future drug development
Eur J Clin Invest (2005) 35 (Suppl I): 33-44

Alban S
From heparins to factor Xa inhibitors and beyond
Eur J Clin Invest (2005) 35 (Suppl I): 12-20 PubMed

Offord R, McRobbie D, Alban S, Gaussem P
Advances in anticoagulant care for the prevention of venous thromboembolism after orthopaedic surgery: A pharmaceutical perspective on Ximelagatran, a novel oral direct thrombin inhibitor
Eur J Hosp Pharmacy (2004) 10(5): 264-270. PubMed

Alban S
Paradigm change in anticoagulation. Natural substances that are selective factor Xa inhibitors
Pharmazie in unserer Zeit (2004) 33: 190-194

Alban S, Blaschek, Seitz R
GA fordert Erstattungsfähigkeit von Phytopharmaka
Pharm Ztg (2003) 148(38): 3456-3458

Alban S
Das Vorsichtsprinzip und seine Auswirkungen im Bereich der Medizin
Krankenhauspharmazie (2003) 24: 367-373

Alban S
Pharmakologie von Heparinen und Polysacchariden
http://www.roche.de/pharma/indikation/fachinfo/blutgerinnung/hsbg/45_alban.pdf
„45. Hamb urger Symposiums über Blutgerinnung u nd Hämostaseologie“, Hamburg, 31.05.-01.06.2002

Alban S
Antikoagulantien: Der Thrombosegefahr vorbeugen
Pharm Ztg (2002) 147 (Nr. 24, 13.06.2002): 2508-2515

Scheffer H, Bauer R, Kopp B, Alban S, Nahrstedt A
Colchicine in dietary supplements.
Pharm Ztg (2001) 146: 58

Alban S
Der Einfluss des Molekulargewichts von Heparin auf den Beitrag von TFPI zur antithrombotischen Aktivität
Hämostaseol (2001) 21, Suppl: 4-7

Alban S
„Damit das Blut besser fließt!“ - Entwicklung neuer blutgerinnungshemmender Substanzen
Blick in die Wissenschaft - Forschungsmagazin der Universität Regensburg (1996) 8: 32-41

Greinacher A, Alban S
Heparinoide als eine Alternative für die parenterale Antikoagulation bei Patienten mit Heparin-induzierter Thrombozytopenie
Hämostaseol (1996) 16: 41-49

Alban S
Toxine - ein zukunftsträchtiges Gebiet der Pharmazie
Dtsch Apoth Ztg (1994) 134, 36: 33-44

Alban S, Franz G
Phytotherapie in der Pädiatrie: Neurodermitis und Ekzeme
Sozialpädiatrie in Praxis und Klinik (1990) 12, 12: 863-868

 

III. Buchbeiträge und Herausgebertätigkeit:

Alban S, Gastpar R:
Development of SPC-ELISA, a new assay principle for the study of sulfated polysaccharide-protein interactions
in: Dumitriu S: “Polysaccharides”
(2008) 2nd edition, Marcel Dekker, New York , in press

Alban S
70. Heparinmonitoring
in: Pötzsch B, et al: “Hämostaseologie”
(2009) 2nd edition, Springer Medizin Verlag, Heidelberg, in press

Alban S
51.1. Heparine und andere Glykoantikoagulanzien
in: Pötzsch B, et al: “Hämostaseologie”
(2009) 2nd edition, Springer Medizin Verlag, Heidelberg, in press

Alban S
20. Kohlenhydrate III: Aminoglykane und Glykosaminoglykane
in: Hänsel R, Sticher O „Pharmakognosie - Phytopharmazie“
(2009) 9. Aufl., Springer Medizin Verlag, Heidelberg : 591-638

Alban S
19. Kohlenhydrate II: Polysaccharide und Polysacchariddrogen
in: Hänsel R, Sticher O „Pharmakognosie - Phytopharmazie“
(2009) 9. Aufl., Springer Medizin Verlag, Heidelberg: 461-590

Alban S, Dingermann T (Hrsg.)
Thrombozytenaggregationshemmer
Pharmazie in unserer Zeit (2009) Jg. 38, Heft 4

Scheer R, Alban S, Becker H, Holzgrabe U, Kemper FH, Kreis W, Matthes H, Schicher H (Hrsg.)
Die Mistel in der Tumortherapie 2 – Aktueller Stand der Forschung und klinische Anwendung
(2009) KVC Verlag, Essen

Scheer R, Alban S, Becker H, Holzgrabe U, Kemper FH, Kreis W, Matthes H, Schicher H (Hrsg.)
Mistletoe in tumour therapy – basic research and clinical practice
Phytomedicine (2007) 14, Suppl. VII

Alban S, Scriba GKE
Kommentar zur Monographie “Danaparoid sodium” PhEur 5.5, 2090
Arzneibuch-Kommentar, Band 5, Monographien D bis H
(2007) 26. Lieferung (PhEur 5.5), Wissenschaftliche Verlagsgesellschaft, Stuttgart, Govi-Verlag, Eschborn, 1-8

Alban S, Scriba GKE
Kommentar zur Monographie “Chondroitin sulfate sodium” PhEur 5.5, 2064
Arzneibuch-Kommentar, Band 4, Monographien C
(2007) 26. Lieferung (PhEur 5.5), Wissenschaftliche Verlagsgesellschaft, Stuttgart, Govi-Verlag, Eschborn, 1-7

Alban S, Greinacher A
Role of sulfated polysaccharides in the pathogenesis of heparin induced thrombocytopenia
in: Warkentin T, Greinacher A: „Heparin-Induced Thrombocytopenia“
(2007) 4th revised and supplemented edition, Informa Healthcare , New York : 167-186

(2007) 8. Aufl., Springer Medizin Verlag, Heidelberg: 515-654

Alban S
20. Kohlenhydrate III: Aminoglykane und Glykosaminoglykane
in: Hänsel R, Sticher O „Pharmakognosie - Phytopharmazie“
(2007) 8. Aufl., Springer Medizin Verlag, Heidelberg: 655-704

Alban S, Blaschek W
19. Kohlenhydrate II: Polysaccharide und Polysacchariddrogen
in: Hänsel R, Sticher O „Pharmakognosie - Phytopharmazie“

Blaschek W, Alban S
18. Kohlenhydrate I: Chemie, wichtige Mono- und Oligosaccharide
in: Hänsel R, Sticher O „Pharmakognosie - Phytopharmazie“
(2007) 8. Aufl., Springer Medizin Verlag, Heidelberg: 473-514

Alban S, Dingermann T (Hrsg.)
Gerinnungsfaktoren
Pharmazie in unserer Zeit (2006) Jg. 35, Heft 1

Alban S, Dingermann T (Hrsg.)
Antikoagulanzien
Pharmazie in unserer Zeit (2004) Jg. 33, Heft 3

Alban S, Greinacher A:
Role of sulfated polysaccharides in the pathogenesis of heparin-induced thrombocytopenia
in: Warkentin T, Greinacher A: „Heparin-Induced Thrombocytopenia“
(2004) 3rd revised and supplemented edition, Marcel Dekker, New York : 197-221

Alban S:
Hydrokolloide aus Algen und Aminoglycane
in: Hänsel R, Sticher O „Pharmakognosie - Phytopharmazie“
(2004) 7. Aufl., Springer-Verlag , Berlin , Heidelberg , New York : 362-381

Alban S, Greinacher A:
Role of sulfated polysaccharides in the pathogenesis of heparin-induced thrombocytopenia
in: Warkentin T, Greinacher A: „Heparin-Induced Thrombocytopenia“
(2000) 1st edition, Marcel Dekker, New York : 155-174;
(2001) 2nd revised, edition: 167-187

Franz G, Paper D, Alban S:
Chapter 5: Pharmacological activities of sulfated carbohydrate polymers
in: Paulsen BS: „Bioactive Carbohydrate Polymers“
(2000) Kluwer Academic Publishers, Dordrecht , The Netherlands: 47-58

Franz G, Alban S:
Kohlenhydrate
in: Steinegger E, Hänsel R „Lehrbuch der Pharmakognosie und Phytopharmazie“
(1999) 6. Aufl., Springer-Verlag , Berlin , Heidelberg , New York : 301-427

Alban S:
Chapter 6: Carbohydrates with anticoagulant and antithrombotic properties
in: Witczak ZJ, Nieforth KA "Carbohydrates in Drug Design"
(1997) Marcel Dekker, New York : 209-276

Alban S, Jeske W, Hoppensteadt D, Fareed J, Franz G:
Biological activities and effects on the platelet aggregation of a structurally defined curdlan sulfate
in: Harenberg J, Casu B: "Non-Anticoagulant Actions of Glycosaminoglycans"
(1996) Plenum Publishing Corporation, New York: 235-242

Alban S, Franz G:
Synthese und antithrombotische Aktivitäten von neuartigen Heparinoiden
in: Hirschelmann R: "Entzündung und verwandte Reaktionen - Neue Erkenntnisse, neue Wirkstoffe"
(1993) Jenapharm GmbH, Jena: 223-232

 

IV. Patent und Patenanmeldung:

Verfahren zur Bestimmung der Qualität von Heparin
Alban S, Lühn S, Schiemann S
PCT Appl. (2009) 27pp, PCT/DE 2009/001215. (03.09.2009)

Médicament anti-inflammatoire et cicatrisant / Anti-inflammatory and healing medicine based on laminarin sulphate
Yvin J-C, Alban S, Franz G in Kooperation mit Goemar-Laboratories, St. Malo, France
PCT Int. Appl. (2002) 37pp, WO 0236132-A1 (10.05.2002)
Priority Application: FR 2000-14118, A (11.03.2000), WO 2001-FR339, W (02.11.2001)
Patent No.: FR 2816213-A1 (10.05.2002), FR 2816213-B1 (22.05.2002); CA 2427744-A1 (10.05.2002); AU 2002023731-A5 (15.05.2002); EP 1337261-A1 (27.08.2003); US 2004127457-A1(01.07.2004), US 7008931-B2 (07.03.2006)

 

V. Posterbeiträge:

Alban S, Schiemann S
Development of a novel heparanase activity assay and identification of potent heparanase inhibitors
Jahrestagung der DPhG 2009, Jena , 28.09.-01.10.2009

Alban S, Lühn S
Simple and rapid quantification of heparins and other sulfated glycans with a fluorescent polymer-assay
Jahrestagung der DPhG 2009, Jena , 28.09.-01.10.2009

Alban S, Schiemann S
Development of a novel heparanase activity assay and identification of potent heparanase inhibitors
XXII Congress of the International Society on Thrombosis and Haemostasis, Boston, 11.-16.07.2009
Abstract publiziert in: J Thromb Haemost (2009) 7, Suppl.2: PP-WE-506

Alban S, Lühn S
Prothrombin time as a simple screening method to identify heparins contaminated with OSCS and similar compounds
XXII Congress of the International Society on Thrombosis and Haemostasis, Boston, 11.-16.07.2009
Abstract publiziert in: J Thromb Haemost (2009) 7, Suppl.2: PP-TH-193

Alban S, Lühn S
A fluorescence microplate assay for direct quantification of heparins and other sulfated carbohydrates
XXII Congress of the International Society on Thrombosis and Haemostasis, Boston, 11.-16.07.2009
Abstract publiziert in: J Thromb Haemost (2009) 7, Suppl.2: PP-TH-192

Schiemann S, Alban S
Detecting heparanase inhibitors with a novel heparanase activity assay fit for routine
53rd Annual Meeting of the GTH (Gesellschaft für Thrombose- und Hämostaseforschung),Wien, 04.-07 .02.2009
Abstract publiziert in: Hämostaseologie (2009) 29: A73 (PP6.6-3)

Lühn S, Alban S
Prothrombin time for detection of contaminated heparins
53rd Annual Meeting of the GTH (Gesellschaft für Thrombose- und Hämostaseforschung),Wien, 04.-07 .02.2009
Abstract publiziert in: Hämostaseologie (2009) 29: A66 (PP4.4-11)

Lühn S, Alban S
A fluorescent microplate assay for quantification of heparins and other sulfated polysaccharides
53rd Annual Meeting of the GTH (Gesellschaft für Thrombose- und Hämostaseforschung),Wien,04.-07 .02.2009
Abstract publiziert in: Hämostaseologie (2009) 29: A87 (PP5.4-6)

Partschefeld J, Alban S
The release of inflammatory cytokines in vitro is effected by semisynthetic pullulan sulfates
Jahrestagung der DPhG 2007, Erlangen , 10.-13.10.2007

Partschefeld J, Alban S
Inhibition of cytokine release in vitro by sulfated polysaccharides from Delesseria sanguinea
Jahrestagung der DPhG 2007, Erlangen , 10.-13.10.2007

Alban S, Groth I
Sulfated polysaccharides from Delesseria sanguinea and their pharmacolcogical activity
Jahrestagung der DPhG 2007, Erlangen , 10.-13.10.2007

Groth I, Alban S
Activities of elastase inhibitors depend on the synthetic substrate
Jahrestagung der DPhG 2007, Erlangen , 10.-13.10.2007

Grünewald N, Alban S
Variability of sulfated polysaccharides from Delesseria sanguinea depending on harvesting time
Jahrestagung der DPhG 2007, Erlangen , 10.-13.10.2007

Grünewald N, Alban S
Extraction and characterization of sulphated polysaccharides from Delesseria sanguinea
Jahrestagung der DPhG 2007, Erlangen , 10.-13.10.2007

Alban S, Venzke K, Blaschek W, Volk R-B
Exopolysaccharide from cyanobacterium Synechocystis aquatilis – production rate, chemical characterization and biological testing
55th Annual Meeting of the Society for Medicinal Plant Research, Graz, 02.-06.09.2007
Abstract publiziert in: Planta Med (2007) 73: 831, P 024

Partschefeld J, Alban S
Effects of semisynthetic pullulan sulfates on the release of inflammatory cytokines in vitro
55th Annual Meeting of the Society for Medicinal Plant Research, Graz , 02.-06.09.2007
Abstract publiziert in: Planta Med (2007) 73: 832, P 028

Partschefeld J, Alban S
Sulfated polysaccharides from Delesseria sanguinea ( Hudson ) Lamouroux inhibit the release of inflammatory cytokines in vitro
55th Annual Meeting of the Society for Medicinal Plant Research, Graz , 02.-06.09.2007
Abstract publiziert in: Planta Med (2007) 73: 832, P 029

Groth I, Alban S
Elastase inhibition assay – the choice of the synthetic substrate determines the result
55th Annual Meeting of the Society for Medicinal Plant Research, Graz , 02.-06.09.2007
Abstract publiziert in: Planta Med (2007) 73: 832, P 033

Grünewald N, Alban S
Seasonal variations of biologically active sulfated polysaccharides extracted from the red alga Delesseria sanguinea (Hudson) Lamouroux from the Baltic Sea
55th Annual Meeting of the Society for Medicinal Plant Research, Graz, 02.-06.09.2007
Abstract publiziert in: Planta Med (2007) 73: 934, P 357

Grünewald N, Alban S
Optimized isolation and structural characterization of biologically active sulfated polysaccharides from the red alga Delesseria sanguinea (Hudson) Lamouroux
55th Annual Meeting of the Society for Medicinal Plant Research, Graz, 02.-06.09.2007
Abstract publiziert in: Planta Med (2007) 73: 932, P 350

Alban S, Ludwig RJ:
Interactions with P-selectin and antimetastatic activities of nadroparin and UFH
XXI Congress of the International Society on Thrombosis and Haemostasis, Geneva, 06.-27.07.2007
Abstract publiziert in: J Thromb Haemost (2007) 1, Suppl. 2: P-M-515

Bauersachs R, Alban S
Perioperatives Bridging mit Fondaparinux (F) bei einer Frau mit Antithrombin (AT)-Mangel
35. Jahrestagung der Deutschen Gesellschaft für Angiologie, Dresden, 06.-09.09.2006
Abstract publiziert in: Vasa (2006) 35, Suppl 69: 68 (PD 4.09)

Simonis D, Fritzsche J, Alban S, Bendas G
Oligosaccharides as efficient selectin inhibitors - detection of binding kinetics by QCM biosensor
DPhG-Jahrestagung and Joint Meeting 2006, Marburg, 04.-07.10.2006

Ludwig RJ, Gille J, Bendas G, Kaufmann R, Boehncke W-H, Alban S
A semi-synthetic ß 1-3 glucansulfate reduces blood borne metastassis ofB16-melanoma cells
ADF, XXXIII. Jahrestagung der Arbeitsgemeinschaft Dermatologische Forschung, Aachen , 23.-25.03.2006 (P149)

Alban S, Becker M, Bendas G, Gille J, Ludwig RJ
The antimetastastic activity of heparin and heparin analogues is based on a multivalent mode of action
50th Annual Meeting of the GTH (Gesellschaft für Thrombose- und Hämostaseforschung), Basel, 15.- 18.02.2006
Abstract publiziert in: Hämostaseologie (2006) 26: A85 (P382)

Ludwig RJ, Schindewolf M, Alban S, Kaufmann R, Lindhoff-Last E, Boehncke W-H
Molecular weight determines the frequency of delayed type hyper-sensitivity reactions to heparin and synthetic oligosaccharides
50th Annual Meeting of the GTH (Gesellschaft für Thrombose- und Hämostaseforschung), Basel, 15.- 18.02.2006
Abstract publiziert in: Hämostaseologie (2006) 26: A59 (P275)

Bauersachs R, Alban S
Perioperative bridging with Fondaparinux in a woman with antithrombin deficiency
50th Annual Meeting of the GTH (Gesellschaft für Thrombose- und Hämostaseforschung), Basel , 15.- 18.02.2006
Abstract publiziert in: Hämostaseologie (2006) 26: A58 (P274)

Alban S, Groth I, Köppen S, Partschefeld J
Pharmacological profile of the antiinflammatory, semisynthetic glucan sulfate PS3
DPhG-Jahrestagung 2005, Mainz , 05.-08.10.2005

Alban S, Ludwig R, Kaufmann R, Diehl S, Boehncke W, Gille J
Correlation between the P-selectin blocking capacity and the antimetastatic activity of different heparins
DPhG-Jahrestagung 2005, Mainz, 05.-08.10.2005

Ludwig RJ, Alban S, Bistrian R, , Boehncke W-H, Henschler R, Kaufmann R, Gille J
Suppression of P-selectin function as distinctive feature of antithrombotic agents to indicate their inhibitory capacity on experimental blood-borne metastasis
3rd International Conference on Thrombosis and Haemostasis Issues in Cancer, Bergamo, Italy, 14.-16.10.2005
Selected for oral poster presentation
Abstract publiziert in: Haematologica Reports 2005; 1: 111 (P-090)

Alban S, Fritzsche J, Ludwig R, Schumacher G, Boehncke W, Bendas G
Semisynthetic P-selectin-antagonists: In vitro- and in vivo investigations of structure-activitiy relationships
3rd International Conference on Thrombosis and Haemostasis Issues in Cancer, Bergamo , Italy , 14.-16.10.2005
Abstract publiziert in: Haematologica Reports 2005; 1: 86 (P-028)

Alban S, Ludwig R, Kaufmann R, Diehl S, Henschler R, Boehncke W, Gille J:
Chemically distinct anticoagulants exert differential effects on experimental melanoma metastasis
49th Annual Meeting of the GTH (Gesellschaft für Thrombose- und Hämostaseforschung), Mannheim , 23.- 26.02.2005

Fritzsche J, Alban S, Schumacher G, Bendas G:
Investigation of P-selectin blocking substances as promising therapeutic agents
DPhG-Jahrestagung and Joint Meeting 2004, Regensburg, 06.-09.10.2004, Abstract Nr. P C37

Alban S, Becker M:
Comparison of different methods for the determination of the PMN-elastase inhibition by sulphated polysaccharides
48th Annual Meeting of the GTH (Gesellschaft für Thrombose- und Hämostaseforschung), Hamburg , 25.-28.02.2004
Abstract publiziert in: Hämostaseologie (2004) 24: A82, P173

Alban S, Becker M:
The mode of action of PS3, a new antiinflammatory and antithrombotic carbohydrate derivative
48th Annual Meeting of the GTH (Gesellschaft für Thrombose- und Hämostaseforschung), Hamburg , 25.-28.02.2004
Abstract publiziert in: Hämostaseologie (2004) 24: A80, P166

Alban S, Becker M:
Investigations of the PMN-elastase inhibitory activity of semisynthetic glucan sulfates
Jahrestagung 2003 der DPhG, Würzburg, 08.-11.10.2003

Nemetz J, Classen B, Alban S, Blaschek W:
Structural investigation of the carbohydrate moiety of a new arabinogalactan-protein with complement modulating properties from Rudbeckia hirta
51st Annual Meeting of the Society for Medicinal Plant Research, Kiel , 31.08.-04.09.2003

Alban S, Becker M, Franz G:
The pharmacological profile of the β-1,3-glucan sulfate PS3 obtained by chemical modification of phycarine isolated fr om Laminaria digitata
51st Annual Meeting of the Society for Medicinal Plant Research, Kiel, 31.08.-04.09.2003

Hemker HC, AlDieri R, Béguin S, Alban S:
Prolongation of the aPTT is far inferior to thrombin generation as an indicator of the heparin anti-coagulant effect
XIX Congress of the International Society on Thrombosis and Haemostasis, Birmingham, 12.-18.07.2003
Abstract publiziert in: J Thromb Haemost (2003) 1, Suppl. 1: P1867

Alban S, Becker M, Franz G:
Anti-inflammatory mech anisms of PS3, a new drug c andidate with both anti-inflammatory and anti-thrombotic activities
XIX Congress of the International Society on Thrombosis and Haemostasis, Birmingham, 12.-18.07.2003
Abstract publiziert in: J Thromb Haemost (2003) 1, Suppl. 1: P0456

Becker M, Alban S:
Tumor cell adhesion to laminin as a target for antimetastatic sulfated polysaccharides
Jahrestagung 2002 der DPhG, Berlin, 09.-12.10.2002
Abstract publiziert in: Arch Pharm Pharm Med Chem (2002) 335, Suppl. 1: P:B2

Türk H, Krämer M, Alban S, Haag R:
Dendritische Polyglycerine für biomedizinische Anwendungen
The Summer School on Medicinal Chemistry, Regensburg, 15.-18.09.2002

Alban S, Classen B, Brunner G, Blaschek W:
Differ entiation between the compl ement modulating effect s of an arabin ogalactan-protei n from Echi nacea purpur ea and heparin
International Congress and 50th Annual Meeting of the Society for Medicinal Plan t Research, Barcelona, 08.-12.09.2002
Abstract publiziert in: Revista de Fitoterapia (2002) 2, Suppl I: A124

Alban S, Franz G, Becker M:
Tumor cell adhesion to laminin is inhibited by antimetastatic sulfated polysaccharides
International Congress and 50th Annual Meeting of the Society for Medicinal Plan t Research, Barcelona, 08.-12.09.2002
Abstract publiziert in: Revista de Fitoterapia (2002) 2, Suppl I: A123

Schellenberg L, Kaiser M, Skrabal C, Wiesenack C, Alban S, Preuner JG:
Anti-Xa activity based dose finding study for dalteparin as an anti-coagulant for extracorporeal circulation in a mini pig model
43. Frühjahrstagung der DGPT (Deutsche. Gesellsch. f. experiment.. u. klin. Pharmakologie u. Toxikologie
Mainz,12.-14.03.2002

Donat F, Duret JP, Santoni A, Cariou R, Necciari J, Magnani H, de Greef R, Alban S:
Pharmacokinetics of fondaparinux sodium in young and elderly healthy subjects: a highly favourable profile
’7th Congress of the European Association of Hospital Pharmacists’, Wien, 20.-22.03.2002

Alban S, Schellenberg L, Kaiser M, Skrabal C, Wiesenack C, Preuner JG
Comparison of methods for monitoring the anticoagulation by a low molecular weight heparin during cardiopulmonary bypass
’46th Annual Meeting of the GTH’ (Gesellschaft für Thrombose- und Hämostaseforschung), Erfurt, 20.-23.02.2002
Abstract publiziert in: Ann Hematol (2002) 81, Suppl I: A2, 5

Alban S, Schellenberg L, Kaiser M, Skrabal C, Wiesenack C, Preuner JG:
Use of a low molecular weight heparin for cardiopulmonary bypass: a dose-finding study in Yucatan mini pigs
’46th Annual Meeting of the GTH’ (Gesellschaft für Thrombose- und Hämostaseforschung), Erfurt, 20.-23.02.2002
Abstract publiziert in: Ann Hematol (2002) 81, Suppl I: A1, 4

Alban S, Becker M:
Modifica tion of the action profile of heparins and sulfated carboh ydrates with elastase inhibitin g and anticoagulant activities
’46th Annual Meeting of the GTH’ (Gesellschaft für Thrombose- und Hämostaseforschung), Erfurt , 20.-23.02.2002
Abstract publiziert in: Ann Hematol (2002) 81, Suppl I: A1, 3

Alban S, Becker M:
Does laminin represent a target for the antimetastatic activity of heparin and sulfated polysaccharides?
’46th Annual Meeting of the GTH’ (Gesellschaft für Thrombose- und Hämostaseforschung), Erfurt , 20.-23.02.2002
Abstract publiziert in: Ann Hematol (2002) 81, Suppl I: A1, 2

Schumacher G, Vogel J, Höpfner M, Alban S, Ikami T, Bendas G, Rothe U:
A dynamic test system to investigate selectin-induced leukocyte adhesion - search for new antiinflammatory compounds (P-Selektin)
Jahrestagung 2001 der DPhG, Halle, 10.-13.10.2001
Abstract publiziert in: Arch Pharm Pharm Med Chem (2001) 334, Suppl. 2: C61

Schellenberg L, Kaiser M, Skrabal C, Wiesenack C, Alban S, Preuner JG:
Predictive i.v.-dalteparin dosage regimen as an anticoagulant for cardiopulmonary bypass in a Yucatan mini pig animal model
25. Herbsttagung der Deutschen Gesellschaft für Kardiologie – Herz- und Kreislaufforschung, Ulm, 27-29.09.2001

Alban S, Stibich H, Bendas G, Franz G:
Structure-dependent inhibition of the selectin-mediated cell adhesion by partial synthetic glucan sulfates
XVIth International Symposium on Glycoconjugates (Glyco XVI), Den Haag, Niederlande, 19-24.08.2001
Abstract publiziert in: Glycoconjugate Journal (2001) 18: 125 (C24.1)

Alban S:
MW-dependent influence of heparin on the form of released TFPI circulating in plasma
XVIIIth Congress of the International Society on Thrombosis and Haemostasis, Paris, France, 06.-12.07.2001
Abstract publiziert in: Thromb Haemost (2001) Suppl: P 2129

Alban S, Stibich H, Vanhove B, Yvin JC, Franz G:
PS3: an nouvel actif anti-inflammatoire issu du milieu marin
European Symposium “Cosm’ing 2001” Cosmetic Ingredients & Biotechnology, Saint-Malo, France, 16.-18.05.2001

Becker M, Franz G, Alban S:
Adhesion of tumor cell adhesion to laminin is inhibited by sulfated carbohydrates
11th Congre ss of the Division of Experimental Cancer Research (AEK) of the German Cancer Society, Heidelber g, 04.-06.04.2001
Abstract publiziert in: J Cancer Res Clin Oncol (2001) 127, Suppl I: S57 / CB22

Becker M, Alban S, Franz G:
Inhibition of tumor cell adhesion and endopeptidases: a way to prevent tumor metastasis?
45th Annual Mee ting of the GTH (Gesellschaft für Thrombose- und Hämostaseforschung), Düsseldorf, 14.-17.02.2001
Abstract publiziert in: Ann Hematol (2001) 80, Suppl I: A6/14

Alban S, Franz G:
Increase of the percentage of free on total plasma TFPI by heparin
45th Annual Mee ting of the GTH (Gesellschaft für Thrombose- und Hämostaseforschung), Düsseldorf, 14.-17.02.2001
Abstract publiziert in: Ann Hematol (2001) 80, Suppl I: A3/4

Alban S, Becker M, Franz G:
Interactions of sulfated polysaccharides with the t-PA-mediated plasminogen activation
45th Annual Mee ting of the GTH (Gesellschaft für Thrombose- und Hämostaseforschung), Düsseldorf, 14.-17.02.2001
Abstract publiziert in: Ann Hematol (2001) 80, Suppl I: A3/3

Alban S
Revised Pharmacological Characterization of Heparins
45th Annual Mee ting of the GTH (Gesellschaft für Thrombose- und Hämostaseforschung), Düsseldorf, 14.-17.02.2001
Abstract publiziert in: Ann Hematol (2001) 80, Suppl I: A3/2

Stibich H, Alban S, Franz G:
Influence of sulfated polysaccharides on the selectin-mediated cell adhesion
3 rd International Congress on Phytomedicine, München, 11.-13.10.2000
Abstract publiziert in: Phytomedicine (2000) 7, Suppl II: P-70

Alban S, Becker M:
Elastase inhibiting and anticoagulant activities of different sulfated polysaccharides
Jahrestagung 2000 der DPhG, Münster, 04.-07.10.2000
Abstract publiziert in: Arch Pharm Pharm Med Chem (2000) 333, Suppl 2: P 3.03

Alban S, Becker M:
Inhibition of tumor cell adhesion to the extracellular matrix by sulfated polysaccharides
Jahrestagung 2000 der DPhG, Münster, 04.-07.10.2000
Abstract publiziert in: Arch Pharm Pharm Med Chem (2000) 333, Suppl 2: P 3.02

Schumacher G, Höpfner M, Alban S, Bendas G, Vogel J, Rothe J:
A bilayer-based model for the investigation of potential inhibitors of inflammatory leukocyte-endothelium-interaction
First Dutch Liposome Workshop, Ameland, September 2000
Abstract publiziert in: Chem Phys Lipids (2000) 107 (1), Suppl

Alban S, Stibich H, Franz G:
Design of sulfated carbohydrates with increased anticomplementary activity and improved efficacy-risk ratio
International C ongress and 48th Annual Meeting of the Socie ty for Medicinal Plant Research, Zü rich, 03.09.-07.09.2000

Becker M, Alban S, Franz G:
Inhibition of tumor cell adhesion to the extracellular matrix by sulfated polysaccharides
International C ongress and 48th Annual Meeting of the Socie ty for Medicinal Plant Research, Zü rich, 03.09.-07.09.2000

Alban S, Gastpar R, Franz G:
Thrombin inhibiting mechanisms of β-1,3-glucan sulfates in dependence on their structure
International C ongress and 48th Annual Meeting of the Socie ty for Medicinal Plant Research, Zü rich, 03.09.-07.09.2000

Alban S, Becker M, Franz G:
Differentiation between the elastase inhibiting and anticoagulant activities of sulfated polysaccha­rides depending on structural variations
International C ongress and 48th Annual Meeting of the Socie ty for Medicinal Plant Research, Zü rich, 03.09.-07.09.2000

Becker M, Alban S, Franz G:
Inhibition of tumor cell adhesion to extracellular matrix by heparin and related polysaccharides
44th Annual Meeting of the GTH (Gesellschaft für Thrombose- und Hämostaseforschung), Freiburg, 16.-19.02.2000
Abstract publiziert in: Ann Hematol (2000) 79, Suppl I: P112

Alban S, Stibich H, Franz G:
Partialsynthetical glucan sulfates as a new principle for biocompatible surfaces
44th Annual Meeting of the GTH (Gesellschaft für Thrombose- und Hämostaseforschung), Freiburg, 16.-19.02.2000
Abstract publiziert in: Ann Hematol (2000) 79, Suppl I: P154

Alban S, Gastpar R, Franz G, Welzel D:
TFPI releasing effect and aXa-activity as two parameters contributing to the individual pharmacological profile of different heparins
44th Annual Meeting of the GTH (Gesellschaft für Thrombose- und Hämostaseforschung), Freiburg, 16.-19.02.2000
Abstract publiziert in: Ann Hematol (2000) 79, Suppl I: P177

Alban S, Klöcking H-P:
Profibrinolytic and an ticoagulant effects of partialsynthetic glucan sulfates with different basic polysaccharide structure
44th Annual Meeting of the GTH (Gesellschaft für Thrombose- und Hämostaseforschung), Freiburg, 16.-19.02.2000
Abstract publiziert in: Ann Hematol (2000) 79, Suppl I: P83

Alban S, Gastpar R, Franz G, Welzel D:
Increase of tot al and free tissue factor pathway inhibi tor (TFPI) in dependenc e on the molecular weight of four heparins applied as a s.c. single dose
XVIIth Congress of the International Society on Thrombosis and Haemostasis, Washington, USA, 14.-21.08.1999
Abstract publiziert in: Thromb Haemost (1999) Suppl: PS 2368

Alban S, Stibich H, Franz G:
Partialsynthetic β-1,3-glucan sulfates as specific complement inhibitors or compounds with anticomplement as well as anticoagulant activities for producing biocompatible surfaces.
XVIIth Congress of the International Society on Thrombosis and Haemostasis , Washington , USA , 14.-21.08.1999
Abstract publiziert in: Thromb Haemost (1999) Suppl: PS 1866

Alban S, Becker-Hagendorff K, Franz G, Kirchmaier CM:
Stimulation of tissue factor pathway inhibitor (TFPI) release from human endothelial cells in culture: comparison of UFH and a LMWH with a high and low molecular weight β-1,3-glucan sulfate
XVIIth Congress of the International Society on Thrombosis and Haemostasis, Washington, USA, 14.-21.08.1999
Abstract publiziert in: Thromb Haemost (1999) Suppl: PS 1788

Becker M, Alban S, Franz G:
Antitumor activity of heparin and related polysaccharides
2000 Years of Natural Products Research - Past, Present and Futu re - Joint Meeting of the ASP, AFERP, GA and PSE,
Amsterdam, 26.-30.07.1999, P 158

Stibich H, Alban S, Franz G:
Inhibition of chemotaxis by ß-1,3-glucan sulfates
2000 Years of Natural Products Research - Past, Present and Futu re - Joint Meeting of the ASP, AFERP, GA and PSE,
Amsterdam, 26.-30.07.1999, P 157

Alban S, Stibich H, Gastpar R, Bergé J-P, Bourgougnon N, Franz G:
Anticoagulant and anticomplement activity of a water-soluble extract from the marine diatom Haslea ostrearia
46th Annual Meeting of the Society for Medicinal Plant Research, Wien, 31.08.-04.09.1998, J11

Alban S, Bourgougnon N, Lahaye M, Chermann J-C, Franz G:
Annual variation of the chemical structure and the anticoagulant and anti-HIV activity of a sulfated glucuronogalactan from Schizymenia dubyi (Rhodophyta, Gigartinales)
46th Annual Meeting of the Society for Medicinal Plant Research, Wien, 31.08.-04.09.1998, J48

Stibich H, Alban S, Franz G:
Anticomplementary activity of ß-1,3-glucan sulfates
46th Annual Congress on Medicinal Plant Research, Wien, 31.08.-04.09.1998

Gastpar R, Franz G, Alban S:
Polysaccharide sulfates: Evaluation of structure-activity relationships by determining the kinetics of the ATIII-mediated thrombin inhibition
42th An nual Meeting of the GTH (Gesellschaft für Thrombose- un d Hämostaseforschung), Fra nkfurt a.M., 25.-28.02.1998
Abstract publiziert in: Ann Hematol (1998) 76, Suppl I: P265

Alban S, Gastpar R, Schauerte A, Franz G:
The mechanisms of action of β-1,3-glucan sulfates inhibiting the thrombin-mediated fibrin formation
42th An nual Meeting of the GTH (Gesellschaft für Thrombose- un d Hämostaseforschung), Frankfurt a.M., 25.-28.02.1998
Abstract publiziert in: Ann Hematol (1998) 76, Suppl I: P264

Alban S, Becker Hagendorff K, Franz G, Kirchmaier CM:
β-1,3-glucan sulfates are superior to heparin in inducing tissue factor pathway inhibitor (TFPI)release from human endothelial cells in culture
42th An nual Meeting of the GTH (Gesellschaft für Thrombose- un d Hämostaseforschung), Frankfurt a.M., 25.-28.02.1998
Abstract publiziert in: Ann Hematol (1998) 76, Suppl I: P263

Zimmermann M, Ittner K-P, Grobecker HF, Alban S:
Do subcutaneously applied unfractionated heparin and low molecular weight heparins influence platelet function assessed by PFA-100 Ô ?
42th An nual Meeting of the GTH (Gesellschaft für Thrombose- un d Hämostaseforschung), Fra nkfurt a.M., 25.-28.02.1998
Abstract publiziert in: Ann Hematol (1998) 76, Suppl I: P255

Alban S, Franz ME, Franz G:
Inf luence on the blood coagulation after oral app lication of Wobenzym ®-Phyto tablet s containing bromelain, p apain and rutin
42th An nual Meeting of the GTH (Gesellschaft für Thrombose- un d Hämostaseforschung), Frankfurt a.M., 25.-28.02.1998
Abstract publiziert in: Ann Hematol (1998) 76, Suppl I: P245

Alban S, Franz ME, Franz G:
In vitro determination of the influence of therapeutically used enzymes on the blood coagulation
42th An nual Meeting of the GTH (Gesellschaft für Thrombose- un d Hämostaseforschung), Fra nkfurt a.M., 25.-28.02.1998
Abstract publiziert in: Ann Hematol (1998) 76, Suppl I: P244

Alban S, Welzel D, Vogel R, Ittner K-P:
The anticoagulating impact of LMWH’s is subject to product-specific endogenous modulation. The significance of differential TFPI-release.
American Heart Association, 70th Scientific Sessions, Orlando , U.S.A. , 09.11.-12.11.1997

Zimmermann M, Ittner K-P, Bucher M, Alban S, Grobecker HF:
Assessment of platelet function with a new in vitro bleeding test in male volunteers following a single 9000 I.U. dose of either certoparin, enoxaparin or liquemin
1997 American Society of Anesthesiologists’s Annual Meeting, San Diego, U.S.A., 18.-22.10.1997
Abstract publiziert in: Anesthesiol (1997) 87/3 Suppl: A443

Alban S, Franz ME, Franz G:
Influence of the therapeutically used enzymes bromelain, papain and trypsin on the blood coagula­tion in vitro
45th Annual Congress on Medicinal Plant Research, Regensburg , 07.-12.09.1997

Alban S, Bourgougnon N, Franz G:
Anticoagulant activity of an antiviral sulfated glucuronogalactan from Schizymenia dubyi (Gigartinales)
XVIth Congress of the International Society on Thrombosis and Haemostasis, Florenz, 06.-12.06.1997
Abstract publiziert in: Thromb Haemost (1997) 77, Suppl: PS2836

Alban S, Schauerte A, Hoppensteadt D, Fu K, Yang L, Iqbal O, Fareed J, Franz G:
In crease of total and especially free TFPI plasma concentration after i.v. application of antico agulant β-1,3-glucan sulfates
XVIth Congress of the International Society on Thrombosis and Haemostasis, Florenz, 06.-12.06.1997
Abstract publiziert in: Thromb Haemost (1997) 77, Suppl: PS1676

Fareed J, Hoppensteadt D, Leitz WH, Alban S, Wolf H:
Heparin and LMWH not only release TFPI from endogenous vascular sites but also favor the equilibrium of free TFPI
41th Annual Meeting of the GTH (Gesellschaft für Thrombose- und Hämostaseforschung), Wien, 22.-26.02.1997
Abstract publiziert in: Ann Hematol (1997) 74, Suppl II: 295

Schauerte A, Alban S , Franz G:
Corellation between anticoagulant and fibrinolytic activity of heparinoids synthesized using natural polysaccharides as starting polymers
41th Annual Meeting of the GTH (Gesellschaft für Thrombose- und Hämostaseforschung) Wien, 22.-26.02.1997
Abstract publiziert in: Ann Hematol (1997) 74, Suppl II: 300

Alban S, Schauerte A, Franz G:
Contact system activation and fibrinolytic activity of β-1,3-glucan sulfate
41th Annual Meeting of the GTH (Gesellschaft für Thrombose- und Hämostaseforschung), Wien, 22.-26.02.1997
Abstract publiziert in: Ann Hematol (1997) 74, Suppl II: 271

Alban S, Schauerte A, Hoppensteadt D, Fu K, L. Yang, Iqbal O, Fareed J, Franz G:
Dissociation between the in vitro anticoagulant activity and the in vivo TFPI release of β-1,3-glucan sulfates
41th Annual Meeting of the GTH (Gesellschaft für Thrombose- und Hämostaseforschung), Wien, 22.-26.02.1997
Abstract publiziert in: Ann Hematol (1997) 74, Suppl II: 303

Alban S, Wolf H, Fareed J, Welzel D, Franz G:
Correlation between the anticoagulant activity of a LMWH and the TFPI-plasma concentration in dependence on dosage and mode of application
41th Annual Meeting of the GTH (Gesellschaft für Thrombose- und Hämostaseforschung), Wien 22.-26.02.1997
Abstract publiziert in: Ann Hematol (1997) 74, Suppl II: 298

Kiefl B, Alban S, Franz G:
Storage stability of herbal drugs co ntaining essential oils / Storage stability and related as pects of Juniperus communis L.
27th International Symposium of Essential Oils, Wien, 08.-11.09.1996

Alban S, Kiefl B, Franz G:
Storage stability of essential oils in plant drugs / Storage stability of essential oils in the fruits of Foeniculum vulgare, Pimpinella anisum and Carum Carvi
44thAnnual Congress on Medicinal Plant Research, Prag, 03.-06.09.1996

Alban S, Franz G:
Mode of action of anticoagulantly active β-1,3-glucan sulfates
XVth Congress of the International Society on Thrombosis and Haemostasis, Jerusalem , 11.-16.06.1995
Abstract publiziert in: Thromb Haemost (1995) 73: 1602

Greinacher A, Alban S, Franz G, Mueller-Eckhardt C:
Characterization of the structural requirements for a carbohydrate based anticoagulant with a reduced risk of inducing the immunological type of heparin-associated thrombocytopenia (HAT)
XVth Congress of the International Society on Thrombosis and Haemostasis, Jerusalem , 11.06.-16.06.1995
Abstract publiziert in: Thromb Haemost (1995) 73: 631

Alban S, Jeske W, Fareed J, Franz G:
Anticoagulant, antiaggregation and antithrombotic activities of a defined curdlan sulfate
39th Annual Meeting of the GTH (Gesellschaft für Thrombose- und Hämostaseforschung),
Berlin, 15.-18.02.1995
Abstract publiziert in: Ann Hematol (1995) 70, Suppl I: P155

Alban S, Franz G:
Synthesis of new heparinoids based on natural seaweed and bacterial polysaccharides
International Research Congress on Natural Products,
Halifax , Nova Scotia , Kanada, 31.07.-04.08.1994

Alban S, Kraus J, Franz G:
Synthesis and analytic of glucansulphates with anticoagulant activities
XVIth International Carbohydrate Symposium, Paris , Frankreich, 05.-10.07.1992

Alban S, Kraus J, Harenberg J, Franz G:
Neutralization of heparin-oligosaccharides and heparinoids by protamine and polybrene
36th Annual Me eting of the GTH (Gesellschaft für Thrombose- und Hämostaseforschung), Heidelberg, 09.-12.02.1992
Abstract publiziert in: Ann Hematol (1992) 64, Suppl: A58

Alban S, Franz G, Welzel D, Wolf H, Dempfle C-E, Harenberg J:
Neutralization of heparins and oligosaccharides by protamine and polybrene
XIIIth Congress of the International Society on Thrombosis and Haemostasis, Amsterdam, 30.06.-06.07.1991
Abstract publiziert in: Thromb Haemost (1991) 65, 6: 1301

 

VI. Dissertationen und Diplomarbeiten:

Karina Ehrig 2015 (Dissertation, CAU Kiel):
Sulfatierte Polysaccharide aus der Braunalge Saccharina latissima – Variabilität der strukturellen Zusammensetzung und Aktivitäten

Simone Schiemann 2012 (Dissertation, CAU Kiel):
Hepari(a)nasen – Entwicklung von Aktivitätsassays sowie ihre Nutzung als Werkzeuge in Reinheitstests

Susanne Lühn 2010 (Dissertation, CAU Kiel):
Quantifizierung und Qualitätskontrolle der Heparine

Niels Grünewald 2009 (Dissertation, CAU Kiel ):
Extraktion und Strukturaufklärung pharmakologisch aktiver sulfatierter Polysaccharide aus der Rotalge Delesseria sanguinea (Hudson) Lamouroux

Inken Groth 2009 (Dissertation, CAU Kiel ):
Interactions of sulfated glycans with the triad haemostasis, inflammation, and metastasis

Simone Schiemann 2008 (Diplomarbeit , CAU Kiel ):
Entwicklung eines Heparinase II-Testes

Tanja Aßmann, 2007 (Diplomarbeit , CAU Kiel ):
Untersuchungen zu neuartigen Antagonisten von Heparinen und sulfatierten Glycanen

Caroline Stahmer, 2007 (Diplomarbeit , CAU Kiel ):
Die Rolle von „JNK-Stresskinasen für die Fresskontrolle und den Energiehaushalt adulter Mäuse

Sandra Stelke, 2006 (Diplomarbeit , CAU Kiel ):
Entwicklung von Methoden zur Untersuchung der Stabilität von Chondrotinsulfat-Lösungen

Heinke Wübbenhorst, 2006 (Diplomarbeit , CAU Kiel ):
Untersuchungen zur P–Selektin-Bindung von Heparinen und sulfatierten Polysacchariden in Abhängigkeit von der Salzform

Gudrun Fuhrmann, 2006 (Diplomarbeit , CAU Kiel ):
Wirkung von B-Vitaminen auf neurale Zellen

Markus Becker, 2006 (Dissertation , Universität Regensburg ):
Struktur-Wirkungs-Beziehungen und Mechanismen der antimetastatischen Aktivität sulfatierter Kohlenhydrate

Maria Laffranchini, 2004 (Dissertation , Universität Regensburg ):
Investigations on the mechanism of action of antiinflammatory glucan sulfates

Helmut Stibich, 2001 (Dissertation , Universität Regensburg ):
Neuartige antiphlogistisch wirksame b -1,3-Glucansulfate: Partialsynthese und physiologische Testung

Susanne Alban, 1999 (Habilitation, Universität Regensburg):
Von sulfatierten Polysacchariden zu neuen potentiellen Arzneistoffen

Anne Schauerte, 1998 (Dissertation , Universität Regensburg ):
Partialsynthetische Heparinoide aus Polysacchariden natürlichen Ursprungs

Nada Lakkis, 1994 (Diplomarbeit , Universität Regensburg ):
Synthese, Strukturaufklärung und antikoagulatorische Wirkung verzweigter Curdlansulfate

Susanne Alban, 1993 (Dissertation, Universität Regensburg):
Synthese und physiologische Testung neuartiger Heparinoide